SEC Form 4 · accession 0001093557-17-000198
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Pacelli
Officer — EVP, Strategy & Corp. Dev.
Period of report
Sep 11, 2017
Accepted (ET)
Sep 13, 2017 · 6:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 11, 2017 | D | 3,347 | $71.8134 | D | 104,740 | D | |
| Common StockF1,F2 | Sep 11, 2017 | D | 3,964 | $71.8134 | D | 100,776 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- F2Included in this number are 54,010 unvested restricted stock units, 27,510 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 19,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 7,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018.